The UK Biobank Exome Sequencing Consortium (UKB-ESC) is a private–public partnership
between the UK Biobank (UKB) and eight biopharmaceutical companies that will complete …

The Pharma Proteomics Project is a precompetitive biopharmaceutical consortium characterizing
the plasma proteomic profiles of 54,219 UK Biobank participants. Here we provide a …

Short insertions and deletions (indels) are the second most abundant form of human genetic
variation, but our understanding of their origins and functional effects lags behind that of …

Purpose The translation of genome sequencing into routine health care has been slow, partly
because of concerns about affordability. The aspirational cost of sequencing a genome is …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease
2019 (COVID-19), a respiratory illness that can result in hospitalization or death. We used …

The UK Biobank Pharma Proteomics Project (UKB-PPP) is a collaboration between the UK
Biobank (UKB) and thirteen biopharmaceutical companies characterising the plasma …

Chuvash polycythemia is an autosomal recessive form of erythrocytosis associated with a
homozygous p.Arg200Trp mutation in the von Hippel-Lindau (VHL) gene. Since this discovery, …

Background Whole genome sequencing is increasingly being used for the diagnosis of
patients with rare diseases. However, the diagnostic yields of many studies, particularly those …

Cardiovascular diseases are the leading cause of premature death and disability worldwide,
with both genetic and environmental determinants. While genome-wide association studies …

Yersinia pestis is the causative agent of the bubonic, septicemic, and pneumonic plagues (also
known as black death) and has been responsible for recurrent devastating pandemics …